Resultados: 45

    Executive summary diagnosis and evaluation of hypersensitivity pneumonitis: CHEST guideline and expert panel report [Pré-print]

    The purpose of this analysis is to provide evidence-based and consensus-derived guidance for clinicians to improve individual diagnostic decision-making for hypersensitivity pneumonitis (HP) and decrease diagnostic practice variability. Approved panelists developed key questions regarding the diagnosis o...

    Actualización 2021 de la guía española de la EPOC (GesEPOC). Diagnóstico y tratamiento del síndrome de agudización de la EPOC [Pré-print]

    En este artículo se presentan las recomendaciones sobre el diagnóstico y tratamiento del síndrome de agudización de la enfermedad pulmonar obstructiva crónica (EPOC) (SAE) de GesEPOC 2021. Como principales novedades, la guía propone una definición y aproximación sindrómica, una nueva clasificaci...

    Spanish COPD guidelines (GesEPOC) 2021: updated pharmacological treatment of stable COPD [Pré-print]

    The Spanish COPD Guidelines (GesEPOC) were first published in 2012, and since then have undergone a series of updates incorporating new evidence on the diagnosis and treatment of COPD. GesEPOC was drawn up in partnership with scientific societies involved in the treatment of COPD and the Spanish Patients...

    Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain

    This guideline covers assessing all chronic pain (chronic primary pain, chronic secondary pain, or both) and managing chronic primary pain in people aged 16 years and over. Chronic primary pain is pain with no clear underlying cause, or pain (or its impact) that is out of proportion to any observable inj...

    Asthma: diagnosis, monitoring and chronic asthma management: Last updated 22 March 2021

    This guideline covers diagnosing, monitoring and managing asthma in adults, young people and children. It aims to improve the accuracy of diagnosis, help people to control their asthma and reduce the risk of asthma attacks. It does not cover managing severe asthma or acute asthma attacks. In March 2021, ...

    Managing asthma in adolescents and adults 2020 asthma guideline update From the National Asthma Education and Prevention Program

    JAMA; 324 (22), 2020
    Asthma is a major public health problem worldwide and is associated with excess morbidity, mortality, and economic costs associated with lost productivity. The National Asthma Education and Prevention Program has released the 2020 Asthma Guideline Update with updated evidence-based recommendations for tr...

    Guía de práctica clínica para el tratamiento de infecciones odontogénicas

    Las infecciones odontogénicas son una de las principales causas de consulta en la práctica odontológica, afectando a individuos de todas las edades.(1, 2) Estas patologías ocasionan considerable dolor y molestias que en caso de no tratarse pueden provocar la pérdida de las piezas dentarias y desenca...

    A living WHO guideline on drugs for COVID-19

    BMJ; 370 (), 2020
    What is the role of drug interventions in the treatment of patients with covid-19? The latest version of this WHO living guidance focuses on remdesivir, following the 15 October 2020 preprint publication of results from the WHO SOLIDARITY trial. It contains a weak or conditional recommendation against th...

    Guidelines for the pharmacological treatment of COVID-19. The task-force/consensus guideline of the Brazilian Association of Intensive Care Medicine, the Brazilian Society of Infectious Diseases and the Brazilian Society of Pulmonology and Tisiology

    Different therapies are currently used, considered, or proposed for the treatment of COVID-19; for many of those therapies, no appropriate assessment of effectiveness and safety was performed. This document aims to provide scientifically available evidence-based information in a transparent interpretatio...

    COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community

    The purpose of this guideline is to ensure the best treatment for adults with suspected or confirmed pneumonia in the community during the COVID-19 pandemic and best use of NHS resources. We have withdrawn our guideline on diagnosing and managing pneumonia in adults until further notice....